Global Body Contouring Devices Market

Body Contouring Devices Market Size, Share, Growth Analysis, By Product Type(Invasive Devices, Invasive Devices), By Application(Non Surgical Skin Resurfacing, Non Surgical Skin Tightening, Cellulite Treatment, Liposuction), By Region - Industry Forecast 2024-2031


Report ID: SQSG35B2021 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 63 | Figures: 75

Body Contouring Devices Market Insights

Body Contouring Devices Market size was valued at USD 1.18 billion in 2019 and is poised to grow from USD 1.35 billion in 2023 to USD 3.35 billion by 2031, growing at a CAGR of 14.3% in the forecast period (2024-2031).

However, the COVID-19 pandemic's arrival has had a significant impact on the aesthetics industry as a whole. However, a lot of aestheticians think that the epidemic may help the market for body sculpting tools develop. The American Society of Plastic Surgeons claims that the pandemic increased people's acceptance of cosmetic surgery. In a study of more than 1,000 women, the group found that 11% of the respondents are now more likely and interested in nonsurgical procedures than they were before the epidemic.

The market for body contouring devices is expected to be driven by the rising number of obesity cases around the world as a result of unhealthy lifestyles. The demand for these treatments is also expected to expand as a result of improved safety and efficacy of these techniques that increase life expectancy. In the upcoming years, the market is expected to grow due to initiatives taken by major companies for product distribution and research, such as M&A, new product launches, and partnerships.

The noninvasive and minimally invasive devices market in North America is expected to grow at a CAGR of 14.4% from 2021 to 2028. Non-Invasive fat reduction, also known as nonsurgical fat reduction, refers to minimally invasive procedures that eliminate intractable subcutaneous fat deposits. Growing demand for body contouring treatments, which are noninvasive and require no recovery time afterward, is one of the main drivers fueling the market's expansion. The non-invasive body contouring laser SculpSure, created by Cynosure, Inc., targets and eliminates about 24% of unwanted fat cells in 25 minutes.

The WHO estimates that obesity is a global epidemic that has tripled since 1975 and that 30% of people worldwide are obese at this time. Sedentary behaviour is a significant underlying factor in obesity, illness, and disability. All developed and developing nations have high levels of physical inactivity. Increased urbanisation has made a significant contribution to the rise in sedentary behaviour, which has in turn increased the prevalence of obesity worldwide.

The global aesthetic and beauty market had been impacted by the COVID-19 pandemic. The pandemic had a significant impact on both invasive and noninvasive aesthetic procedures, including the body contouring industry. In the first half of 2021, operations like non-invasive fat removal, injection lipolysis, invasive liposuction, soft tissue fillers, facelifts, eye lifts, eyelid surgeries, laser skin resurfacing, rhinoplasty, and tummy tucks saw a 20% decline.

US Body Contouring Devices Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The body contouring devices market is expected to grow at a compound annual growth rate of 14.3% from 2023 to 2031.

The FDA has not cleared any dermal filler, including silicone, for injection in body contouring procedures.

Body Contouring Devices Market size was valued at USD 1.18 billion in 2019 and is poised to grow from USD 1.35 billion in 2023 to USD 3.35 billion by 2031, growing at a CAGR of 14.3% in the forecast period (2024-2031).

Many of these firms are quickly choosing to expand geographically, collaborate strategically, and form alliances through mergers and acquisitions in developing and prosperous regions. Evolve Tone was certified by Health Canada and given to InMode Ltd. in June 2021. With this approval, Evolve platform will become Canada's only three distinct body remodelling technologies Tite, Trim, and Tone all in one hands-free device. The following are a few of the leading companies in the body-contouring device market. '3M Company', 'Dentsply Sirona Inc.', 'Danaher Corporation', 'GC Corporation', 'Ivoclar Vivadent AG', 'Kuraray Noritake Dental Inc.', 'Mitsui Chemicals, Inc.', 'Patterson Companies, Inc.', 'Septodont Holding', 'Ultradent Products Inc.', 'VOCO GmbH', 'DMG Chemisch-Pharmazeutische Fabrik GmbH', 'Henry Schein Inc.', 'SHOFU Dental Corporation', 'BISCO Inc.', 'Coltene Holding AG', 'DiaDent Group International', 'FKG Dentaire SA', 'Keystone Industries', 'Premier Dental Products Company'

One of the key factors expected to accelerate the growth and demand for body contouring devices is the increase in awareness of noninvasive and minimally invasive body contouring techniques. Over the forecast period of 2021 to 2028, it is also expected that increased safety brought about by minimally invasive and aesthetic procedures will help drive the expansion of the global market. Additionally, the launch of cutting-edge technologies and an increase in obesity rates are projected to boost the market's expansion. Additionally, among the important factors expected to propel the growth of the body contouring devices market are the quick advancements in aesthetics technology and the rise in awareness of body contouring.

The popularity of non-invasive and minimally invasive technologies may be attributed to the comparatively inexpensive cost of the operation and its few negative effects. As these procedures satisfy the patient's need for a rapid recovery and minimal stress, they raise demand, which benefits the manufacturers. The usage of minimally invasive surgery methods, which are already used in a number of body contouring specializations, is expected to rise over the projected period. For instance, the US Food and Drug Administration in July 2021 approved Allergan's CoolTone, a New Body-Contouring Device with Magnetic Muscle Stimulation (MMS). Additionally, it is projected that the adoption of minimally invasive procedures and the global rise in obesity would accelerate the segment's growth throughout the projection period.

In 2021, North America held the greatest revenue share of 35.8% in the global market for body contouring devices. Throughout the forecast period, the segment is expected to display a considerable CAGR. This is attributable to a growing elderly population, a robust healthcare system, clear reimbursement guidelines, the presence of significant market participants, and improvements in aesthetic body reshaping operations. Additionally, factors like high acceptance and openness toward body contouring treatments and a rising pool of consumers who are concerned with their looks are projected to drive the noninvasive body contouring market in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Body Contouring Devices Market

Report ID: SQSG35B2021

$5,300
BUY NOW GET FREE SAMPLE